Cargando…
Designing high affinity target-binding peptides to HLA-E: a key membrane antigen of multiple myeloma
Multiple myeloma (MM) is a plasma cell malignancy that is currently incurable. Finding new targets and designing drugs are crucial for the treatment of MM. The two datasets (GSE6691 and GSE39754) are used to screen highly expressed antigen on MM cells. HLA-E was an ideal target for it was a hub gene...
Autores principales: | Yang, Ying, Sun, Mingli, Yu, Zhaojin, Liu, Jinwei, Yan, Wei, Liu, Zhuogang, Wei, Minjie, Wang, Hongtao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655190/ https://www.ncbi.nlm.nih.gov/pubmed/33115963 http://dx.doi.org/10.18632/aging.103858 |
Ejemplares similares
-
HLA-E Binding Peptide as a Potential Therapeutic Candidate for High-Risk Multiple Myeloma
por: Yang, Ying, et al.
Publicado: (2021) -
Identification of cancer/testis antigen 2 gene as a potential hepatocellular carcinoma therapeutic target by hub gene screening with topological analysis
por: Liu, Jinwei, et al.
Publicado: (2019) -
Skp2 inhibitor SKPin C1 decreased viability and proliferation of multiple myeloma cells and induced apoptosis
por: Yang, Ying, et al.
Publicado: (2019) -
3pHLA-score improves structure-based peptide-HLA binding affinity prediction
por: Conev, Anja, et al.
Publicado: (2022) -
The Analysis of Key Factors Related to ADCs Structural Design
por: Tang, Haichao, et al.
Publicado: (2019)